Pancreatic cancer is the seventh leading cause of cancer-related mortality worldwide. According to the American Cancer Society, it is the eleventh most common cancer diagnosed in both men and women in the United States. Pancreatic ductal adenocarcinoma (PDAC) comprises 90% of all pancreatic malignancies and is associated with poor clinical outcome because of late diagnosis and resistance to therapy. In addition, studies show that the tumor microenvironment has become an emerging interest in cancer research due to its complex components and unique characteristics that aid in cancer initiation, maintenance, and progression. Accumulating evidence signifies that tumor associated macrophages (TAMs) play a vital role in cancer progression by init...
Pancreatic ductal adenocarcinoma (PDAC) is highly chemo-resistant and has a five year survival rate ...
Pancreatic cancer is associated with a highly abundant stroma and low-grade inflammation. In the loc...
Pancreatic ductal adenocarcinoma (PDAC) is amongst the most fatal malignancies and its development i...
Pancreatic cancer is the seventh leading cause of cancer-related mortality worldwide. According to t...
Pancreatic cancer is the fourth cause of cancer-related death with a 5-year survival rate less than ...
Pancreatic cancer is the product of microenvironment alterations which emerge from inflammatory sign...
Pancreatic cancer ranks as third deadliest cancer worldwide in both men and women. The lack of diagn...
Pancreatic ductal adenocarcinoma (PDAC) is still one of the most aggressive solid malignancies with ...
PhDPancreatic ductal adenocarcinoma is a highly desmoplastic tumour, and non-malignant stromal cells...
At the time of diagnosis, almost 80% of pancreatic cancer patients present with new-onset type 2 dia...
The pancreatic ductal adenocarcinoma microenvironment is composed of a variety of cell types and mar...
Better understanding of pancreatic diseases, including pancreatic adenocarcinoma (PDAC), is an urgen...
Tumor associated macrophages (TAM) and myofibroblasts are key drivers in cancer that are associated ...
BACKGROUND: Protein kinase D1 (PKD1) is a serine–threonine kinase that regulates various functions w...
Pancreatic cancer is associated with a highly abundant stroma and low-grade inflammation. In the loc...
Pancreatic ductal adenocarcinoma (PDAC) is highly chemo-resistant and has a five year survival rate ...
Pancreatic cancer is associated with a highly abundant stroma and low-grade inflammation. In the loc...
Pancreatic ductal adenocarcinoma (PDAC) is amongst the most fatal malignancies and its development i...
Pancreatic cancer is the seventh leading cause of cancer-related mortality worldwide. According to t...
Pancreatic cancer is the fourth cause of cancer-related death with a 5-year survival rate less than ...
Pancreatic cancer is the product of microenvironment alterations which emerge from inflammatory sign...
Pancreatic cancer ranks as third deadliest cancer worldwide in both men and women. The lack of diagn...
Pancreatic ductal adenocarcinoma (PDAC) is still one of the most aggressive solid malignancies with ...
PhDPancreatic ductal adenocarcinoma is a highly desmoplastic tumour, and non-malignant stromal cells...
At the time of diagnosis, almost 80% of pancreatic cancer patients present with new-onset type 2 dia...
The pancreatic ductal adenocarcinoma microenvironment is composed of a variety of cell types and mar...
Better understanding of pancreatic diseases, including pancreatic adenocarcinoma (PDAC), is an urgen...
Tumor associated macrophages (TAM) and myofibroblasts are key drivers in cancer that are associated ...
BACKGROUND: Protein kinase D1 (PKD1) is a serine–threonine kinase that regulates various functions w...
Pancreatic cancer is associated with a highly abundant stroma and low-grade inflammation. In the loc...
Pancreatic ductal adenocarcinoma (PDAC) is highly chemo-resistant and has a five year survival rate ...
Pancreatic cancer is associated with a highly abundant stroma and low-grade inflammation. In the loc...
Pancreatic ductal adenocarcinoma (PDAC) is amongst the most fatal malignancies and its development i...